First Medical Device to Help Diagnose ADHD Approved
The Neuropsychiatric EEG-Based Assessment Aid (NEBA) records and analyzes electric impulses produced by the brain's nerve cells, the agency said in a news release. The non-invasive device, which takes about 20 minutes to produce complete results, measures brain wave frequencies called theta and beta waves. The theta/beta ratio has been shown to be higher in young people with ADHD, the FDA said.
Citing the American Psychiatric Association, the FDA said about 9 percent of U.S. adolescents have ADHD, and the average age of diagnosis is 7 years. Children with ADHD typically have behavior problems, trouble paying attention and hyperactivity.
Device maker NEBA Health submitted data from a clinical study of 275 children and adolescents, ranging in age from 6 to 17. The study found that the new device helped professionals better diagnose children with ADHD when combined with a psychological assessment, compared to a psychological assessment alone.
NEBA is based in Augusta, Ga.
More information
The U.S. Centers for Disease Control and Prevention has more about ADHD.
Sarra Sounds Off Ep. 35: EI baseball, girls lacrosse and plays of the week On the latest episode of "Sarra Sounds Off," we look at East Islip baseball's inspirational comeback story, Jared Valluzzi has the plays of the week and Tess Ferguson breaks down the top defensive players in girls lacrosse.
Sarra Sounds Off Ep. 35: EI baseball, girls lacrosse and plays of the week On the latest episode of "Sarra Sounds Off," we look at East Islip baseball's inspirational comeback story, Jared Valluzzi has the plays of the week and Tess Ferguson breaks down the top defensive players in girls lacrosse.
